Published in Proc Natl Acad Sci U S A on December 01, 1970
Isolation of a major cell surface glycoprotein from fibroblasts. Proc Natl Acad Sci U S A (1974) 3.30
Intercellular contact and cell-surface galactosyl transferase activity (cell culture-mouse-radioautography-contact inhibition-cis-and trans-galactosylation). Proc Natl Acad Sci U S A (1972) 1.70
Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. Biochim Biophys Acta (2007) 1.62
Cholera toxin and cell growth: role of membrane gangliosides. Proc Natl Acad Sci U S A (1974) 1.46
Carbohydrate catabolism and the enhancement of uptake of galactose in hamster cells transformed by polyoma virus. Proc Natl Acad Sci U S A (1973) 1.34
Absence of a specific ganglioside galactosyltransferase in mouse cells transformed by murine sarcoma virus. Proc Natl Acad Sci U S A (1974) 1.29
Glycolipid synthesis in normal and virus-transformed hamster cell lines. Proc Natl Acad Sci U S A (1972) 1.12
Alterations of membrane glycopeptides in human colonic adenocarcinoma. Proc Natl Acad Sci U S A (1974) 1.09
Transformation of chick-embryo fibroblasts by wild-type and temperature-sensitive Rous sarcoma virus alters adenylate cyclase activity. Proc Natl Acad Sci U S A (1973) 1.08
Control of growth by picolinic acid: differential response of normal and transformed cells. Proc Natl Acad Sci U S A (1977) 1.01
Changes in membrane structure associated with cell contact. Proc Natl Acad Sci U S A (1973) 1.00
Scanning electron microscopy of in vitro chemically transformed mouse embryo cells. J Cell Biol (1976) 0.87
Anti-ganglioside anti-idiotypic vaccination: more than molecular mimicry. Front Oncol (2012) 0.87
Cell contact-dependent increase in membrane D-galactopyranosyl-like residues on normal, but not virus- or spontaneously-transformed, murine fibroblasts. Proc Natl Acad Sci U S A (1973) 0.84
GM3 and cancer. Glycoconj J (2015) 0.83
Ganglioside patterns and phenotypic characteristics in a normal variant and a transformed back variant of a simian virus 40-induced hamster tumor cell line. J Cell Biol (1973) 0.81
Cell mitotic cycle synthesis of NIL hamster glycolipids including the Forssman antigen. J Cell Biol (1974) 0.80
Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro. Glycoconj J (2000) 0.79
Long-chain neutral glycolipids and gangliosides of murine fibroblast lines and their low- and high-tumourigenic hybrids. Proc Natl Acad Sci U S A (1976) 0.79
Studies on the relationship between concanavalin A and SV40-transformed human fibroblasts. Br J Cancer (1976) 0.78
Cell density-dependent changes of glycosphingolipid biosynthesis in cultured human skin fibroblasts. Glycoconj J (2001) 0.78
Self-recognition of high-mannose type glycans mediating adhesion of embryonal fibroblasts. Glycoconj J (2012) 0.77
Putative inhibitory effects of chrysotile, crocidolite, and amosite mineral fibers on the more complex surface membrane glycolipids and glycoproteins. Environ Health Perspect (1980) 0.75
Glycolipids and fatty acids of two dog kidney cell lines. Biochem J (1979) 0.75
Loss of cell-population-density-dependent incorporation of fucose into the lipid fraction of cultured human tumour cells. Biochem J (1978) 0.75
A difference in the architecture of the surface membrane of normal and virally transformed cells. Proc Natl Acad Sci U S A (1969) 6.03
The surface properties of cancer cells: a review. Cancer Res (1962) 5.37
Structural difference in sites on the surface membrane of normal and transformed cells. Nature (1969) 3.81
Membranes of animal cells. II. The metabolism and turnover of the surface membrane. J Cell Biol (1968) 2.75
Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines. Proc Natl Acad Sci U S A (1968) 2.75
Differences between the electrical charge carried by normal and homologous tumour cells. Nature (1956) 2.46
Comparative studies on the carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. II. Separation of glycoproteins and glycopeptides by sephadex chromatography. Biochemistry (1969) 2.24
Organizational difference of cell surface "hematoside" in normal and virally transformed cells. Biochem Biophys Res Commun (1968) 2.04
Gangliosides in DNA virus-transformed and spontaneously transformed tumorigenic mouse cell lines. Proc Natl Acad Sci U S A (1969) 1.76
Surface antigen(s) of SV40-transformed tumor cells. Virology (1970) 1.66
RAPID TRANSFORMATION OF HUMAN FIBROBLASTS WITH LOW GROWTH POTENTIAL INTO ESTABLISHED CELL LINES BY SV40. J Cell Physiol (1963) 1.63
Thin-layer chromatographic studies of human brain gangliosides. Biochim Biophys Acta (1966) 1.35
Metabolic inhibition of mammalian uridine diphosphate galactose 4-epimerase in cell cultures and in tumor cells. J Biol Chem (1966) 1.35
Investigations on cellular blood-group substances. I. Isolation and chemical composition of blood-group ABH and Le-b isoantigens of sphingoglycolipid nature. Biochemistry (1968) 1.31
CLONAL GROWTH OF PRIMARY HUMAN CELL CULTURES. Exp Cell Res (1964) 1.16
SURFACE MUCOPOLYSACCHARIDES OF POLYOMA VIRUS TRANSFORMED CELLS. J Cell Physiol (1963) 1.03
Composition and synthesis of gangliosides in rat hepatocyte and hepatoma cell lines. J Biol Chem (1969) 0.99
THE CELL SURFACE IN TUMOR VIRUS INFECTION. Cancer Res (1963) 0.88
ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science (1990) 4.45
Molecular genetic basis of the histo-blood group ABO system. Nature (1990) 4.17
Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu Rev Biochem (1981) 3.66
Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J (1983) 2.80
Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N Engl J Med (1992) 2.52
Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group). J Immunol (1972) 2.37
An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells. J Clin Invest (1996) 2.35
CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. Proc Natl Acad Sci U S A (1991) 2.34
New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J Biol Chem (1983) 2.08
Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood (1995) 2.04
Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02
Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem (1986) 2.00
Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res (1985) 1.96
Structures and organization of cell surface glycolipids dependency on cell growth and malignant transformation. Biochim Biophys Acta (1975) 1.91
ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang (1989) 1.91
Specific interaction between Lex and Lex determinants. A possible basis for cell recognition in preimplantation embryos and in embryonal carcinoma cells. J Biol Chem (1989) 1.88
Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J Biol Chem (1984) 1.79
Changes in a surface-labelled galactoprotein and in glycolipid concentrations in cells transformed by a temperature-sensitive polyoma virus mutant. Nature (1974) 1.77
Blood group ABH and Ii antigens of human erythrocytes: chemistry, polymorphism, and their developmental change. Semin Hematol (1981) 1.76
Tumor-associated carbohydrate antigens. Annu Rev Immunol (1984) 1.76
Domain structure of human plasma fibronectin. Differences and similarities between human and hamster fibronectins. J Biol Chem (1983) 1.71
Glycosphingolipids as tumor-associated and differentiation markers. J Natl Cancer Inst (1983) 1.71
Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland. J Biol Chem (1984) 1.70
Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer (1990) 1.70
Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling. J Biol Chem (1998) 1.69
Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. J Cell Biol (1995) 1.66
A multivalent lacto-N-fucopentaose III-lysyllysine conjugate decompacts preimplantation mouse embryos, while the free oligosaccharide is ineffective. J Exp Med (1984) 1.63
Functional domain structure of fibronectin. Proc Natl Acad Sci U S A (1980) 1.59
Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res (1988) 1.54
A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1. J Biol Chem (1982) 1.53
A new cell surface, detergent-insoluble glycoprotein matrix of human and hamster fibroblasts. The role of disulfide bonds in stabilization of the matrix. J Biol Chem (1981) 1.52
Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness. Proc Natl Acad Sci U S A (1992) 1.52
A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science (1983) 1.51
Sialyl-Tn- and neuron-specific enolase-positive minimally differentiated erythroleukemia. Intern Med (2000) 1.46
The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Natl Acad Sci U S A (1985) 1.40
Domain structure of hamster plasma fibronectin. Isolation and characterization of four functionally distinct domains and their unequal distribution between two subunit polypeptides. J Biol Chem (1981) 1.38
Blood group i and I activities of "lacto-N-norhexaosylceramide" and its analogues: the structural requirements for i-specificities. Biochem Biophys Res Commun (1978) 1.37
Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. Biochemistry (1989) 1.37
Cell surface expression of the McDonough strain of feline sarcoma virus fms gene product (gp 140fms). Cell (1984) 1.37
Glycolipids of tumor cell membrane. Adv Cancer Res (1973) 1.36
Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen. Proc Natl Acad Sci U S A (1985) 1.35
Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). J Biol Chem (1984) 1.35
Developmental change and genetic defect in the carbohydrate structure of band 3 glycoprotein of human erythrocyte membrane. J Biol Chem (1979) 1.35
Sugar-nucleotide donor specificity of histo-blood group A and B transferases is based on amino acid substitutions. J Biol Chem (1990) 1.35
A revised structure for the Forssman glycolipid hapten. J Biol Chem (1971) 1.34
Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts. Studies with domain-specific antibodies. J Biol Chem (1985) 1.34
Carbohydrate catabolism and the enhancement of uptake of galactose in hamster cells transformed by polyoma virus. Proc Natl Acad Sci U S A (1973) 1.34
Human histo-blood group A2 transferase coded by A2 allele, one of the A subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal. Biochem Biophys Res Commun (1992) 1.33
Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. Cancer Res (1989) 1.32
Genomic organization of human histo-blood group ABO genes. Glycobiology (1995) 1.31
Investigations on cellular blood-group substances. I. Isolation and chemical composition of blood-group ABH and Le-b isoantigens of sphingoglycolipid nature. Biochemistry (1968) 1.31
The hapten structure of a developmentally regulated glycolipid antigen (SSEA-1) isolated from human erythrocytes and adenocarcinoma: a preliminary note. Biochem Biophys Res Commun (1981) 1.31
N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. Biochemistry (1996) 1.29
Mechanism of fibronectin-mediated cell migration: dependence or independence of cell migration susceptibility on RGDS-directed receptor (integrin). Exp Cell Res (1989) 1.28
Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen. J Immunol (1987) 1.27
GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells. J Biol Chem (1998) 1.27
The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide. J Biol Chem (1988) 1.27
Expression of LeY and extended LeY blood group-related antigens in human malignant, premalignant, and nonmalignant colonic tissues. Cancer Res (1986) 1.26
Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res (1999) 1.26
A ceramide tetrasaccharide of human erythrocyte membrane reacting with anti-type XIV pneumococcal polysaccharide antiserum. Biochim Biophys Acta (1973) 1.25
Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2. J Biol Chem (1982) 1.25
Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain. J Biol Chem (1984) 1.22
Transformation by the v-fms oncogene product: role of glycosylational processing and cell surface expression. Mol Cell Biol (1985) 1.22
A possible role of sphingosine in induction of apoptosis by tumor necrosis factor-alpha in human neutrophils. FEBS Lett (1994) 1.21
Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto-N-glycosyl type II chain. J Biol Chem (1981) 1.21
The monoclonal antibody directed to difucosylated type 2 chain (Fuc alpha 1 leads to 2Gal beta 1 leads to 4[Fuc alpha 1 leads to 3]GlcNAc; Y Determinant). J Biol Chem (1983) 1.20
Cell surface modification by endo-beta-galactosidase. Change of blood group activities and release of oligosaccharides from glycoproteins and glycosphingolipids of human erythrocytes. J Biol Chem (1979) 1.20
Glycolipid expression in lymphoma cell variants: chemical quantity, immunologic reactivity, and correlations with susceptibility to NK cells. J Immunol (1981) 1.20
Cell adhesion, spreading, and motility of GM3-expressing cells based on glycolipid-glycolipid interaction. J Biol Chem (1991) 1.19
Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J Clin Invest (1992) 1.19
Enhanced glycolipid: -galactosyltransferase activity in contact-inhibited hamster cells, and loss of this response in polyoma transformants. Biochem Biophys Res Commun (1971) 1.19
Glycoconjugate expression during embryogenesis and its biological significance. Bioessays (1990) 1.18
Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int J Cancer (1996) 1.18
Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain. J Biol Chem (1984) 1.17
Human liver fibronectin complementary DNAs: identification of two different messenger RNAs possibly encoding the alpha and beta subunits of plasma fibronectin. Biochemistry (1986) 1.16
Cloning and characterization of DNA complementary to human UDP-GalNAc: Fuc alpha 1----2Gal alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA. J Biol Chem (1990) 1.15
Microscale methylation analysis of glycolipids using capillary gas chromatography-chemical ionization mass fragmentography with selected ion monitoring. Methods Enzymol (1987) 1.14
Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells. Cancer Res (1983) 1.14
Surface carbohydrates of hamster fibroblasts. I. Chemical characterization of surface-labeled glycosphingolipids and aspecific ceramide tetrasaccharide for transformants. J Biol Chem (1975) 1.14
Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: its possible identity with "A-like antigen" in human cancer. Proc Natl Acad Sci U S A (1977) 1.14
Lewisx- and sialylated Lewisx-related antigen expression in human malignant and nonmalignant colonic tissues. Cancer Res (1986) 1.14
Further studies on cell adhesion based on Le(x)-Le(x) interaction, with new approaches: embryoglycan aggregation of F9 teratocarcinoma cells, and adhesion of various tumour cells based on Le(x) expression. Glycoconj J (1994) 1.13
A novel sphingosine-dependent protein kinase (SDK1) specifically phosphorylates certain isoforms of 14-3-3 protein. J Biol Chem (1998) 1.13
Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine. Cancer Res (1986) 1.13
Selectin GMP-140 (CD62; PADGEM) binds to sialosyl-Le(a) and sialosyl-Le(x), and sulfated glycans modulate this binding. Biochem Biophys Res Commun (1991) 1.12
Glycolipid antigens of human polymorphonuclear neutrophils and the inducible HL-60 myeloid leukemia line. J Immunol (1985) 1.11
Le(y) antigen expression is correlated with apoptosis (programmed cell death). Glycobiology (1993) 1.11
Monosialogangliosides of human myelogenous leukemia HL60 cells and normal human leukocytes. 2. Characterization of E-selectin binding fractions, and structural requirements for physiological binding to E-selectin. Biochemistry (1996) 1.10
A ceramide analogue inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N,N-dimethylsphingosine synthesis. Biochemistry (1990) 1.10
The signal modulator protein 14-3-3 is a target of sphingosine- or N,N-dimethylsphingosine-dependent kinase in 3T3(A31) cells. Biochem Biophys Res Commun (1995) 1.10
Quantitative measurement of sphingosine 1-phosphate in biological samples by acylation with radioactive acetic anhydride. Anal Biochem (1995) 1.10
Analysis of the specificity of five murine anti-blood group A monoclonal antibodies, including one that identifies type 3 and type 4 A determinants. Biochemistry (1985) 1.10
Possible role of ceramide in defining structure and function of membrane glycolipids. Proc Natl Acad Sci U S A (1982) 1.09
Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazonensis. Immunogenicity and role in parasite binding and invasion of macrophages. J Biol Chem (1993) 1.09
Sphingosine and its methylated derivative N,N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines. Int J Cancer (1996) 1.09
Structures of ceramide tetrasaccharides from various sources: uniqueness of rat kidney ceramide tetrasaccharide. J Lipid Res (1972) 1.09